• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Orthokeratology Lens Market

    ID: MRFR/HC/6746-CR
    101 Pages
    Rahul Gotadki
    August 2019

    Orthokeratology Lens Market Research Report Information By Materials (Silicone Acrylate, Fluorosilicone Acrylate, and Fluorocarbon Acrylate), By Applications (Myopia, Hyperopia, and Others), By End Users (Hospitals and Ophthalmology Clinics), And By Region (North America, Europe, Asia-Pacific, And the Rest Of The World) – Market Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Orthokeratology Lens Market Infographic
    Purchase Options

    Orthokeratology Lens Market Summary

    As per Market Research Future Analysis, the Global Orthokeratology Lens Market was valued at USD 0.75 billion in 2024 and is projected to grow to USD 1.52 billion by 2035, at a CAGR of 6.62% from 2025 to 2035. The market is driven by the increasing prevalence of refractive errors, rising diagnoses of conditions like myopia and astigmatism, and advancements in lens technology. Orthokeratology lenses, which reshape the cornea and are worn overnight, are gaining popularity, especially among children, due to their non-surgical nature and effectiveness in slowing myopia progression.

    Key Market Trends & Highlights

    The orthokeratology lens market is witnessing significant growth due to changing consumer preferences and technological advancements.

    • The market is expected to grow from USD 0.8 billion in 2024 to USD 1.30 billion by 2032.
    • Myopia segment dominated the market in 2022, with approximately 1.9 billion people affected globally.
    • Silicone acrylate lenses held a market share of around 44-49% in 2022.
    • North America accounted for USD 1.07 billion in 2022, driven by advancements in lens technology.

    Market Size & Forecast

    2024 Market Size USD 0.75 Billion
    2035 Market Size USD 1.52 Billion
    CAGR (2024-2035) 6.62%

    Major Players

    Major players include Menicon Co. Ltd, CooperVision Inc, Euclid Systems Corporation, Alcon Inc, and Bausch & Lomb Incorporated.

    Orthokeratology Lens Market Trends

    Changning consumer preference for non-surgical vision correction procedures to drive market growth

    Orthokeratology lenses are special gas-permeable lenses suitable for all age groups and designed for corneal reshaping. These lenses can be worn overnight, preventing patients from wearing spectacles or contact lenses during the day. Several recent studies have found that orthokeratology treatment is one of the effective ways to slow myopia progression in children. These lenses are also referred to as daytime ortho-K lenses by some healthcare professionals in some nations. Several vision correction surgeries are available for refractive errors like myopia and astigmatism, such as refractive lens exchange, LASIK, and photorefractive keratectomy (PRK).

    However, some of the adverse effects of these operations, such as dry eye, itching, blurred glare, vision, and halos around lights at night, cause a decline in the population's use of these procedures. For instance, a 2020 article states that 20–40% of LASIK patients experience dry eye and itching after the operation, and 20% of LASIK patients have trouble with contrast, glare, and halos around light at night.

    One of the significant factors influencing children's preference for orthokeratology lenses is the limited options available to them for correcting refractive errors. Another factor contributing to children's increased use of these lenses is eliminating the need to wear contact lenses and glasses during the day. Additionally, improvements in technology have made it easier to fit lenses, which has helped the general public become more aware of and adopt lenses, thereby driving the orthokeratology lens market CAGR.

    The increasing prevalence of myopia among children and adolescents is driving a notable shift towards non-surgical vision correction methods, such as orthokeratology lenses, which are gaining traction as a viable alternative to traditional corrective eyewear.

    Centers for Disease Control and Prevention (CDC)

    Orthokeratology Lens Market Drivers

    Market Growth Projections

    The Global Orthokeratology Lens Market Industry is projected to experience substantial growth over the next decade. With a market value anticipated to reach 1.57 USD Billion by 2035, the industry is poised for expansion driven by various factors such as increasing myopia prevalence and technological advancements. The compound annual growth rate of 6.35% from 2025 to 2035 indicates a robust market trajectory. This growth is supported by rising consumer awareness and the adoption of non-surgical vision correction methods, which collectively contribute to the industry's positive outlook.

    Increasing Myopia Prevalence

    The rising prevalence of myopia globally is a key driver for the Global Orthokeratology Lens Market Industry. As studies indicate, myopia affects approximately 30% of the global population, and this figure is expected to rise significantly in the coming years. This surge in myopia cases is particularly pronounced in urban areas, where lifestyle factors contribute to increased screen time and reduced outdoor activities. Consequently, the demand for effective myopia management solutions, such as orthokeratology lenses, is likely to grow. The Global Orthokeratology Lens Market Industry is projected to reach 0.8 USD Billion in 2024, reflecting the urgent need for innovative corrective options.

    Regulatory Support and Standards

    Regulatory support and established standards for orthokeratology lenses are crucial factors driving the Global Orthokeratology Lens Market Industry. Government agencies and health organizations are increasingly recognizing the importance of safe and effective vision correction methods. This recognition leads to the development of guidelines and regulations that ensure the quality and safety of orthokeratology lenses. Such regulatory frameworks not only enhance consumer confidence but also encourage manufacturers to innovate and improve their products. The resulting market stability and growth potential are likely to benefit the Global Orthokeratology Lens Market Industry.

    Growing Awareness of Vision Health

    Growing awareness of vision health among consumers is significantly influencing the Global Orthokeratology Lens Market Industry. Educational campaigns and initiatives by healthcare professionals are increasingly informing the public about the benefits of early intervention in myopia management. This heightened awareness encourages parents to seek effective solutions for their children, thereby driving demand for orthokeratology lenses. As more individuals recognize the importance of maintaining optimal vision health, the market is likely to expand. The Global Orthokeratology Lens Market Industry is expected to experience a compound annual growth rate of 6.35% from 2025 to 2035, reflecting this trend.

    Technological Advancements in Lens Design

    Technological advancements in lens design are transforming the Global Orthokeratology Lens Market Industry. Innovations such as improved materials and manufacturing techniques enhance the comfort and effectiveness of orthokeratology lenses. For instance, the introduction of high-Dk materials allows for better oxygen permeability, which is crucial for overnight wear. These advancements not only improve patient satisfaction but also expand the market by attracting new users. As a result, the Global Orthokeratology Lens Market Industry is poised for growth, with projections indicating a market value of 1.57 USD Billion by 2035, driven by these technological improvements.

    Rising Adoption of Non-Surgical Vision Correction

    The rising adoption of non-surgical vision correction methods is a notable driver for the Global Orthokeratology Lens Market Industry. Many individuals prefer non-invasive options over surgical procedures due to concerns about risks and recovery times. Orthokeratology lenses offer a reversible and effective solution for myopia management without the need for surgery. This preference is particularly strong among parents seeking safe options for their children. As a result, the Global Orthokeratology Lens Market Industry is likely to see increased adoption rates, contributing to its overall growth and market expansion.

    Market Segment Insights

    Orthokeratology Lens Materials Insights

    Based on materials, the Orthokeratology Lens Market segmentation includes silicone acrylate, fluorosilicone acrylate, and fluorocarbon acrylate. The silicone acrylate segment held the majority share in 2022, contributing to around ~44-49% of the Orthokeratology Lens Market revenue. Silicone is highly flexible, making it a popular material for contact lenses. The production of silicone acrylate lenses has been pushed by fluoro acrylate's high refractive index and other advantages. Thus, various benefits of silicone acrylate orthokeratology lenses are anticipated to boost the segment's growth.

    Increased FDA approvals for orthokeratology lenses used to treat refractive disorders and technical advancements in lens design and materials are expected to drive global market growth.

    Orthokeratology Lens Applications Insights

    Applications have bifurcated the Orthokeratology Lens Market data into myopia, hyperopia, and others. The myopia segment dominated the market in 2022 and is likely to be the faster-growing segment in the forecasted period 2022-2030. Myopia is becoming more common in children and the elderly worldwide, and patients are choosing non-invasive techniques over refractive surgeries, helping the segment grow. According to the journal Investigative Ophthalmology and Visual Science, approximately 1.9 billion people have myopia, or nearly 27.08% of the global population. Myopia will rank among the major factors contributing to permanent blindness worldwide over the upcoming years.

    Orthokeratology lenses are popular among children owing to the higher prevalence of myopia in this age group. According to the WHO, 52.13% of people are predicted to have myopia by 2050. Orthokeratology lenses help slow myopia progression, especially in children, while promoting the segmental market growth.

    January 2022: Euclid Systems Corporation collaborated with the Global Specialty Lens Symposium to raise myopia awareness and educate eye care providers (ECPs) about advanced orthokeratology lenses and proactive myopia management.

    Orthokeratology Lens End Users Insights

    Based on End Users, the global orthokeratology lens industry has been segmented into hospitals and ophthalmology clinics. Hospitals held the most prominent segment revenue share in 2022. Investment opportunities in orthokeratology lenses are continually increasing in hospitals due to the growing incidence of eye-related illnesses like glaucoma and cataracts, driving the market growth. The increased adoption of orthokeratology lenses in hospitals owing to advanced treatment facilities is further expected to fuel the segment's growth. However, the use of orthokeratology lenses may differ between hospitals worldwide, limiting market expansion.

    Additionally, several hospitals are opening combined ophthalmic centers for many refractive conditions, which is predicted to accelerate the segment's growth.

    Figure 2: Orthokeratology Lens Market, by End Users, 2023 & 2032 (USD Billion)

    Get more detailed insights about Orthokeratology Lens Market

    Regional Insights

    By Region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Orthokeratology Lens market accounted for USD 1.07 billion in 2022 and is anticipated to exhibit a significant CAGR growth over the study period. Recent advancements in orthokeratology lenses, the introduction of overnight ortho-K lenses, and flexibility and choice are some factors driving North American market growth. The increasing number of cases of visual impairment, combined with the increased use of orthokeratology lenses in Canada and the United States, is expected to create numerous growth opportunities throughout the region.

    Moreover, major US market players such as Johnson & Johnson Vision, CooperVision, and Bausch & Lomb Inc are expected to increase their regional orthokeratology lens market share in the coming years. For example, in April 2021, Johnson & Johnson Vision partnered with Menicon to combine their expertise with the scope, science, and capabilities of J&J Vision to address the rising number of pediatric cases of myopia. Menicon will develop therapeutic contact lenses as part of the collaboration, while J&J Vision will focus on increasing the range of new products.

    Furthermore, the major countries studied in the market report are the U.S., Germany, Canada, France, the UK, Spain, Italy, Japan, India, Australia, China, South Korea, and Brazil.

    Figure 3: ORTHOKERATOLOGY LENS MARKET SHARE BY REGION 2023 (%)ORTHOKERATOLOGY LENS MARKET SHARE BY REGION 2022

    Source: Primary Research, Secondary Research, Market Research Future Database, and Analyst Review

    The European orthokeratology lens market has the second-largest market share, owing to the region's growing senior population and preference for correcting optical issues without surgery or traditional glasses. Moreover, rising government initiatives to increase the availability of high-quality treatment drive orthokeratology lens market demand in this region. The usage of orthokeratology lenses among medical professionals is anticipated to rise with the prevalence of ocular conditions like myopia and presbyopia. Technological advancements and increasing the number of products obtaining CE approval are further expected to boost regional growth.

    Additionally, the German orthokeratology lens market held the largest market share, and the UK orthokeratology lens market was the fastest-growing market in the European region.

    The Asia-Pacific Orthokeratology Lens Market is anticipated to grow at the fastest CAGR from 2022 to 2030, owing to the adoption of advanced products such as SEED and ProCornea and the region's growing senior population. Besides, an increase in awareness of eye disorders and the expansion and launches of significant players in this region are expected to drive market growth. In December 2020, for example, a Menicon Alpha Corporation subsidiary formed ALPHA (WUXI) Co. Ltd, a local Chinese Subsidiary, to increase the volume and business of orthokeratology lenses in China.

    Moreover, the growing number of ophthalmic clinics and hospitals in Asian countries is expected to boost demand for orthokeratology lenses over the projected period. Furthermore, China’s orthokeratology lens market held the largest market share, and the Indian orthokeratology lens market was the fastest-growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Major market players are concentrating on meeting the growing demand for these orthokeratology lens treatments owing to the increasing prevalence of refractive errors worldwide. The orthokeratology lens industry offers non-surgical refractive error correction by altering the cornea's curvature with rigid lenses specially made for each patient. Industry players are also pursuing various strategic market development initiatives to expand their global footprint, including new product introductions, contractual arrangements, acquisitions and mergers, increased R&D investments, and collaborative efforts with other organizations.

    The orthokeratology lens market’s major players, including Menicon Co. Ltd, CooperVision Inc, Euclid Systems Corporation, Alcon Inc, and others, are investing heavily in research and development to produce efficient and cost-effective orthokeratology lenses. Manufacturing these lenses locally to cut operating costs is one of the central business strategies used by production companies in the global orthokeratology lens industry to benefit consumers and expand the market sector.

    Johnson & Johnson Vision (JJV) is a subsidiary of Johnson & Johnson that consists of two divisions: Johnson & Johnson Vision Care (Contact Lens) and Johnson & Johnson Surgical Vision. Among the services offered by the company are intraocular lenses, phacoemulsification systems, laser vision correction systems, viscoelastic, Microkeratomes, and associated products used in cataract and refractive surgery. The company operates in 24 countries and sells its products in about 60 nations. Johnson & Johnson Vision received FDA clearance for its first orthokeratology lens for myopia management in May 2021.

    Also, CooperVision is a global contact lens company that serves eye care professionals and lens wearers in over 130 nations. They create various innovative soft contact lenses based on scientific and technological advances. It was founded in 1980 and is headquartered in California, United States. Cooper Companies Inc purchased C&E GP Specialists Inc, one of the leading orthokeratology lens manufacturers & distributors, to broaden CooperVision's specialty eye care business and address myopia's growing severity and prevalence.

    Key Companies in the Orthokeratology Lens Market market include

    Industry Developments

    • Q1 2024: Johnson & Johnson Vision Launches New Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management Johnson & Johnson Vision announced the commercial launch of its Acuvue Abiliti Overnight Therapeutic Lenses in the United States, expanding its orthokeratology product portfolio for pediatric myopia management.
    • Q2 2024: Menicon Receives CE Mark Approval for Menicon Z Night Ortho-K Lenses in Europe Menicon Co., Ltd. received CE Mark approval for its Menicon Z Night orthokeratology lenses, allowing the company to market and distribute the product across the European Union for overnight myopia correction.
    • Q2 2024: Bausch + Lomb Expands Paragon CRT Ortho-K Lens Distribution in Asia-Pacific Bausch + Lomb announced the expansion of its Paragon CRT orthokeratology lens distribution network in key Asia-Pacific markets, aiming to meet rising demand for myopia management solutions.
    • Q3 2024: EssilorLuxottica Announces Strategic Partnership with Euclid Vision to Advance Ortho-K Lens Technology EssilorLuxottica entered into a strategic partnership with Euclid Vision to co-develop next-generation orthokeratology lenses, focusing on improved comfort and efficacy for pediatric myopia control.
    • Q3 2024: FDA Grants 510(k) Clearance to Brighten Optix for New Overnight Ortho-K Lens Brighten Optix received 510(k) clearance from the FDA for its new overnight orthokeratology lens, enabling commercial sales in the United States for non-surgical myopia management.
    • Q4 2024: CooperVision Opens New Ortho-K Lens Manufacturing Facility in Singapore CooperVision inaugurated a new manufacturing facility in Singapore dedicated to the production of orthokeratology lenses, aiming to strengthen its supply chain and serve the growing Asia-Pacific market.
    • Q4 2024: MiracLens LLC Secures Series B Funding to Accelerate Ortho-K Lens R&D MiracLens LLC announced the completion of a Series B funding round, raising capital to support research and development of advanced orthokeratology lens designs for pediatric and adult patients.
    • Q1 2025: Alcon Appoints New Head of Global Ortho-K Business Unit Alcon announced the appointment of Dr. Emily Chen as the new Head of its Global Ortho-K Business Unit, signaling a renewed focus on innovation and market expansion in the orthokeratology sector.
    • Q1 2025: Euclid Vision Corp. Launches Euclid Emerald Max Ortho-K Lens in North America Euclid Vision Corp. launched its new Euclid Emerald Max orthokeratology lens in North America, designed for enhanced comfort and efficacy in overnight myopia management.
    • Q2 2025: Contex Inc. Announces Partnership with Major U.S. Optometry Chain for Ortho-K Lens Distribution Contex Inc. entered into a distribution partnership with a leading U.S. optometry chain to expand access to its orthokeratology lenses for myopia control.
    • Q2 2025: LUCID Korea Ltd. Receives Korean Ministry of Food and Drug Safety Approval for New Ortho-K Lens LUCID Korea Ltd. received regulatory approval from the Korean Ministry of Food and Drug Safety for its latest orthokeratology lens, enabling nationwide commercial launch.
    • Q3 2025: Paragon Vision Sciences Wins Major Supply Contract with Chinese Hospital Group Paragon Vision Sciences secured a multi-year supply contract to provide orthokeratology lenses to one of China's largest hospital groups, supporting the country's growing demand for myopia management solutions.

    Future Outlook

    Orthokeratology Lens Market Future Outlook

    The Orthokeratology Lens Market is projected to grow at a 6.62% CAGR from 2024 to 2032, driven by increasing myopia prevalence, technological advancements, and rising consumer awareness.

    New opportunities lie in:

    • Develop innovative lens materials to enhance comfort and effectiveness. Expand distribution channels through online platforms and telehealth services. Invest in educational campaigns targeting parents about myopia management options.

    By 2035, the Orthokeratology Lens Market is expected to achieve substantial growth, reflecting evolving consumer needs and technological progress.

    Market Segmentation

    Orthokeratology Lens Regional Outlook

    • North America
    • US
    • Canada
    • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Rest of the World
    • Middle East
    • Africa
    • Latin America

    Orthokeratology Lens End Users Outlook

    • Hospitals
    • Ophthalmology Clinics

    Orthokeratology Lens Materials Outlook

    • Silicone Acrylate
    • Fluorosilicone Acrylate
    • Fluorocarbon Acrylate

    Orthokeratology Lens Applications Outlook

    • Myopia
    • Hyperopia
    • Others

    Report Scope

    Report Attribute/MetricDetails
    Market Size 2024USD 0.75 billion
    Market Size 20351.52 (Value (USD Billion))
    Compound Annual Growth Rate (CAGR)6.62% (2025 - 2035)
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2018-2022
    Market Forecast UnitsValue (USD Billion)
    Report CoverageMarket Competitive Landscape, Revenue Forecast, Growth Factors, and Trends
    Segments CoveredMaterials, Applications, End Users, and Region
    Geographies CoveredNorth America, Europe, Asia Pacific, and the Rest of the World
    Countries CoveredThe U.S., Canada, France, the UK, Spain, Italy, China, Japan, India, Germany, Australia, South Korea, and Brazil
    Key Companies ProfiledCooperVision Inc, GP Specialists, Menicon Co. Ltd, Euclid Systems Corporation, Procornea Netherlands B.V., Visioneering Technologies Inc, Bausch & Lomb Incorporated, Alcon Inc, Brighten Optix, Contamac Ltd
    Key Market OpportunitiesIncrease in ortho-k lens research and development activities Emerging medical technological advancements
    Key Market DynamicsIncreased prevalence of vision problems like myopia and presbyopia Rising demands for corrective lenses and contact lenses to treat refractive errors
    Market Size 20250.80 (Value (USD Billion))

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the projected growth of the Orthokeratology Lens market?

    The Orthokeratology Lens market is the expected increase in total market value of 1.52 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Orthokeratology Lens market?

    Orthokeratology Lens market size was valued at approximately 0.75 billion USD in 2024. This figure will reach 1.52 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Orthokeratology Lens market?

    Orthokeratology Lens market is expected to grow at a CAGR of 6.62% between 2025 and 2035.

    How much will the Orthokeratology Lens market be worth by 2035?

    Orthokeratology Lens market is expected to be worth of 1.52 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Orthokeratology Lens market perform over the next 10 years?

    Over the next 10 years the Orthokeratology Lens market is expected to shift from usd billion 0.75 to 1.52 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region held the largest revenue share in the orthokeratology lens market?

    North America had the largest revenue share of the global market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials